CORT and breast carcinoma: In recent years, several groups of researchers have demonstrated that stress hormones such as CORT, through their GRs, participate in cancer cell progression, specifically in breast cancer, because the presence of CORT is classified as an endocrine malignancy [65,66,67,68].